A Study of the Safety and Effectiveness of Experimental Uproleselan With Chemotherapy for Acute Myeloid Leukemia (blood cancer)
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at UC Davis UCLA UCSD
- Dates
- study startedestimated completion
- Principal Investigator
- by Matthew Wieduwilt, MD, PhD (ucsd)Gary Schiller, MD (ucla)Brian Jonas, MD (ucdavis)
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientists at UC Health
- Matthew Wieduwilt, MD, PhD (ucsd)
Associate Clinical Professor, Medicine. Authored (or co-authored) 25 research publications. Research interests: Acute lymphoblastic leukemia (ALL) · Acute myeloid leukemia (AML) · Bone marrow transplant · Clinical trial design and conduct. - Gary Schiller, MD (ucla)
Professor-in-Residence, Medicine. Authored (or co-authored) 74 research publications. - Brian Jonas, MD (ucdavis)
Associate Professor, Hematology and Oncology. Authored (or co-authored) 48 research publications.
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- GlycoMimetics Incorporated
- ID
- NCT03616470
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated